Bionano Genomics (BNGO) EBT Margin (2017 - 2026)
Bionano Genomics (BNGO) posted EBT Margin of 124.02% for Q1 2026, down 153.15% sequentially from 233.33% in Q4 2025, and down 7608.0% YoY from 1.65% in Q1 2025.
Bionano Genomics (BNGO) EBT Margin (2017 - 2026) Analysis & Trends
Bionano Genomics has reported EBT Margin for 10 years, with the latest figure at 124.02% in Q1 2026.
- Quarterly EBT Margin fell 7608.0% year-over-year to 124.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.67% (up 27617.0% YoY) and the FY2025 annual result came in at 0.43%, up 36430.0% from the prior year.
- EBT Margin fell to 124.02% in Q1 2026 per BNGO's latest filing, from 233.33% in the prior quarter.
- Over five years, EBT Margin peaked at 233.33% in Q4 2025 and troughed at 1207.63% in Q3 2023.
- A 5-year average of 362.35% and a median of 409.73% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2023 and 2025: EBT Margin slumped 76751 bps in 2023, then jumped 61294 bps in 2025.
- Over 5 years, EBT Margin stood at 448.84% in 2022, then climbed by 9 bps to 409.73% in 2023, then soared by 40 bps to 246.53% in 2024, then jumped by 195 bps to 233.33% in 2025, then tumbled by 153 bps to 124.02% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 124.02%, 233.33%, and 115.23% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 36.46% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 11.12% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -1.63% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 32.40% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 3.06% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 20.65% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.89% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -4.48% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 5.34% |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | -90.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -90.76% |
| Mar 31, 2026 | -124.02% |
| Dec 31, 2025 | 233.33% |
| Sep 30, 2025 | -115.23% |
| Jun 30, 2025 | -101.69% |
| Mar 31, 2025 | -47.93% |
| Dec 31, 2024 | -246.53% |
| Sep 30, 2024 | -728.17% |
| Jun 30, 2024 | -208.44% |
| Mar 31, 2024 | -358.54% |
| Dec 31, 2023 | -409.73% |
| Sep 30, 2023 | -1,207.63% |
| Jun 30, 2023 | -448.85% |
| Mar 31, 2023 | -500.31% |
| Dec 31, 2022 | -448.84% |
| Sep 30, 2022 | -440.12% |
| Jun 30, 2022 | -481.51% |
| Mar 31, 2022 | -525.68% |
| Dec 31, 2021 | -455.66% |
| Sep 30, 2021 | -445.07% |